EARLY CANCER DETECTION THROUGH TRANSCRIPTOMIC ANALYSIS OF HOST IMMUNE CELLS AND CIRCULATING TUMOR DNA: TARGETING FUTURE IMMUNE PREVENTION

StatusActive
Effective start/end date01/09/201831/12/2022

Funding

  • Emil Aaltosen säätiö: €210,000.00
  • Suomen lääketieteen säätiö: €150,000.00